Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
42.14(c) 42.02(c) 42.33(c) 42.84(c) 42.91(c) Last
7 467 356 4 840 199 3 863 518 3 992 009 5 347 059 Volume
+0.26% -0.28% +0.74% +1.20% +0.16% Change
More quotes
Financials (USD)
Sales 2021 11 758 M - -
Net income 2021 1 490 M - -
Net Debt 2021 5 912 M - -
P/E ratio 2021 42,9x
Yield 2021 -
Sales 2022 12 727 M - -
Net income 2022 1 826 M - -
Net Debt 2022 3 783 M - -
P/E ratio 2022 33,5x
Yield 2022 -
Capitalization 60 971 M 60 971 M -
EV / Sales 2021 5,69x
EV / Sales 2022 5,09x
Nbr of Employees 38 000
Free-Float 84,2%
More Financials
Company
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm... 
More about the company
Ratings of Boston Scientific Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BOSTON SCIENTIFIC CORPORATION
06/07BOSTON SCIENTIFIC  : Argus Adjusts Boston Scientific's Price Target to $50 From ..
MT
06/03BOSTON SCIENTIFIC  : Insider Sales at Boston Scientific (BSX) are Significant an..
MT
06/02INSIDER TRENDS : Insider Adds to Selling Trend at Boston Scientific
MT
06/02INSIDER TRENDS : Boston Scientific Insider Extends 90-Day Selling Trend
MT
05/26SECTOR UPDATE : Health Care Stocks Slipping Ahead of Close
MT
05/26BOSTON SCIENTIFIC  : Needham Downgrades Boston Scientific to Hold From Buy, Expe..
MT
05/25BOSTON SCIENTIFIC  : Barclays Starts Boston Scientific at Overweight with $51 Pr..
MT
05/25BOSTON SCIENTIFIC  : Completes CE Mark for EXALT™ Model B Single-Use Bronc..
PR
05/24BOSTON SCIENTIFIC  : to Participate in Bernstein's 37th Annual Strategic Decisio..
PR
05/21BOSTON SCIENTIFIC  : Helping India, Brazil and Other Countries Fight Surges in C..
PU
05/21BOSTON SCIENTIFIC  : Her Determination in the Service of Others
PU
05/18BOSTON SCIENTIFIC  : Late-Breaking Registry Data at EuroPCR Congress Demonstrate..
PR
05/17BOSTON SCIENTIFIC  : ELEGANCE Patient Registry Focuses on Women and People of Co..
PU
05/14BOSTON SCIENTIFIC INVESTIGATION INIT : Kahn Swick & Foti, LLC Investigates the O..
BU
05/13BOSTON SCIENTIFIC CORP  : Entry into a Material Definitive Agreement, Terminatio..
AQ
More news
News in other languages on BOSTON SCIENTIFIC CORPORATION
04/28Tagesvorschau International
04/28TAGESVORSCHAU : Termine am 28. April 2021
03/29CAROTTE & BÂTON  : comment l'Arabie saoudite attire-t-elle les entreprises sur s..
02/03Morning Briefing - International
02/03TAGESVORSCHAU : Termine am 03. Februar 2021
More news
Analyst Recommendations on BOSTON SCIENTIFIC CORPORATION
More recommendations
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 32
Average target price 48,98 $
Last Close Price 42,91 $
Spread / Highest target 21,2%
Spread / Average Target 14,1%
Spread / Lowest Target -4,45%
EPS Revisions
Managers and Directors
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy SVP, Chief Information & Digital Officer
Edward F. Mackey Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION19.36%60 971
THERMO FISHER SCIENTIFIC-0.14%182 817
DANAHER CORPORATION11.20%176 194
INTUITIVE SURGICAL, INC.5.64%102 341
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.10.33%89 297
ILLUMINA, INC.22.48%66 163